Literature DB >> 19222912

Active absorption of ginsenoside Rg1 in vitro and in vivo: the role of sodium-dependent glucose co-transporter 1.

Jing Xiong1, Minjie Sun, Jianxin Guo, Luosheng Huang, Shujing Wang, Boyu Meng, Qineng Ping.   

Abstract

OBJECTIVES: Our previous study suggested that adrenaline (epinephrine) could be an effective absorption enhancer for ginsenoside Rg1 (Rg1). This study focused on the transport mechanism of Rg1 and the role of sodium-dependent glucose co-transporter 1 in the regulation of Rg1 uptake after exposure to adrenaline.
METHODS: Caco-2 cells were used as an in-vitro model to assess the absorption mechanism of Rg1. Also the effect of D-glucose on adrenaline-induced absorption of Rg1 was investigated in vivo in rats. KEY
FINDINGS: Results showed that the uptake of Rg1 was temperature-dependent. The transport from the basolateral side to the apical side was significantly lower compared with that from the apical to the basolateral side (P < 0.01). The transport of Rg1 was concentration dependent (Km was 41.60 mM, V(max) was 353.75 mol/cm(2)/min). Cells incubated with D-glucose-free medium exhibited significantly greater Rg1 uptake (+ 62.6%) compared with cells in D-glucose-containing medium. The data indicated that sodium-dependent glucose co-transporter 1 was involved in the transport of Rg1. Adrenaline-induced uptake of Rg1 was significantly inhibited in the presence of phlorizin and the absence of Na+. In the in-vivo study in rats, it was found that after co-administration with D-glucose, the adrenaline-induced absorption of Rg1 was inhibited. The area under the concentration-time curve (AUC(0 --> infinity)) value was significantly decreased from 64.57 +/- 27.08 to 1.37 +/- 0.42 microg/ml h (P < 0.001).
CONCLUSIONS: The data suggested that adrenaline enhanced the absorption of Rg1 by regulating sodium-dependent glucose co-transporter 1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19222912     DOI: 10.1211/jpp/61.03.0014

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  6 in total

1.  Paving the Road Toward Exploiting the Therapeutic Effects of Ginsenosides: An Emphasis on Autophagy and Endoplasmic Reticulum Stress.

Authors:  Milad Ashrafizadeh; Shima Tavakol; Reza Mohammadinejad; Zahra Ahmadi; Habib Yaribeygi; Tannaz Jamialahmadi; Thomas P Johnston; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Pharmacology of ginsenosides: a literature review.

Authors:  Kar Wah Leung; Alice Sze-Tsai Wong
Journal:  Chin Med       Date:  2010-06-11       Impact factor: 5.455

3.  Ginsenosides, ingredients of the root of Panax ginseng, are not substrates but inhibitors of sodium-glucose transporter 1.

Authors:  Shengli Gao; Hirotaka Kushida; Toshiaki Makino
Journal:  J Nat Med       Date:  2016-09-12       Impact factor: 2.343

4.  Increased effects of ginsenosides on the expression of cholesterol 7α-hydroxylase but not the bile salt export pump are involved in cholesterol metabolism.

Authors:  Atsushi Kawase; Ayano Yamada; Yuko Gamou; Chika Tahara; Fumiaki Takeshita; Kazuya Murata; Hideaki Matsuda; Keiichi Samukawa; Masahiro Iwaki
Journal:  J Nat Med       Date:  2012-10-30       Impact factor: 2.343

5.  Chondroprotective Effects of Ginsenoside Rg1 in  Human Osteoarthritis Chondrocytes and a Rat Model  of Anterior Cruciate Ligament Transection.

Authors:  Wendan Cheng; Juehua Jing; Zhen Wang; Dongying Wu; Yumin Huang
Journal:  Nutrients       Date:  2017-03-10       Impact factor: 5.717

6.  Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer.

Authors:  Chao Hong; Dan Wang; Jianming Liang; Yizhen Guo; Ying Zhu; Jiaxuan Xia; Jing Qin; Huaxing Zhan; Jianxin Wang
Journal:  Theranostics       Date:  2019-06-09       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.